Piper Sandler Issues Pessimistic Forecast for Celsius (NASDAQ:CELH) Stock Price

Celsius (NASDAQ:CELH) had its price target reduced by investment analysts at Piper Sandler from $69.00 to $61.00 in a note issued to investors on Wednesday, Marketbeat.com reports. The firm currently has an “overweight” rating on the stock. Piper Sandler’s target price suggests a potential upside of 46.39% from the stock’s previous close.

Other equities research analysts also recently issued reports about the stock. Citigroup dropped their price objective on shares of Celsius from $73.00 to $65.00 and set a “buy” rating on the stock in a research report on Friday, November 7th. Cowen reissued a “buy” rating on shares of Celsius in a report on Tuesday, September 2nd. Roth Capital restated a “buy” rating on shares of Celsius in a research note on Thursday, October 2nd. Jefferies Financial Group set a $72.00 price objective on Celsius and gave the stock a “buy” rating in a research report on Wednesday, September 3rd. Finally, B. Riley increased their price objective on Celsius from $56.00 to $75.00 and gave the company a “buy” rating in a report on Tuesday, September 2nd. Twenty analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $64.16.

Celsius Stock Performance

Shares of CELH opened at $41.67 on Wednesday. Celsius has a 1 year low of $21.10 and a 1 year high of $66.74. The stock has a market capitalization of $10.74 billion, a PE ratio of 416.70, a PEG ratio of 0.75 and a beta of 1.01. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.61 and a current ratio of 1.89. The stock has a 50-day simple moving average of $49.65 and a 200-day simple moving average of $50.41.

Celsius (NASDAQ:CELH) last released its earnings results on Thursday, November 6th. The company reported $0.42 earnings per share for the quarter, topping analysts’ consensus estimates of $0.28 by $0.14. The firm had revenue of $725.11 million for the quarter, compared to analyst estimates of $703.68 million. Celsius had a net margin of 3.03% and a return on equity of 41.88%. The firm’s revenue was up 172.9% compared to the same quarter last year. On average, analysts predict that Celsius will post 0.89 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Celsius news, major shareholder William H. Milmoe sold 40,000 shares of the business’s stock in a transaction that occurred on Friday, October 10th. The stock was sold at an average price of $62.50, for a total value of $2,500,000.00. Following the completion of the sale, the insider owned 221,245 shares in the company, valued at approximately $13,827,812.50. The trade was a 15.31% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Jarrod Langhans sold 5,000 shares of the stock in a transaction that occurred on Thursday, October 16th. The shares were sold at an average price of $65.00, for a total value of $325,000.00. Following the completion of the sale, the chief financial officer directly owned 99,227 shares of the company’s stock, valued at $6,449,755. The trade was a 4.80% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 2.55% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Alliancebernstein L.P. raised its holdings in shares of Celsius by 26.3% in the first quarter. Alliancebernstein L.P. now owns 18,045,178 shares of the company’s stock valued at $642,769,000 after buying an additional 3,753,055 shares during the last quarter. BNP Paribas Financial Markets grew its holdings in shares of Celsius by 389.1% during the third quarter. BNP Paribas Financial Markets now owns 1,713,170 shares of the company’s stock worth $98,490,000 after buying an additional 1,362,867 shares during the last quarter. Scopus Asset Management L.P. acquired a new position in Celsius in the 2nd quarter valued at about $59,382,000. Ilex Capital Partners UK LLP purchased a new stake in Celsius during the 2nd quarter valued at approximately $55,966,000. Finally, Holocene Advisors LP raised its stake in Celsius by 130.6% during the 2nd quarter. Holocene Advisors LP now owns 2,108,041 shares of the company’s stock valued at $97,792,000 after acquiring an additional 1,193,707 shares during the last quarter. 60.95% of the stock is owned by hedge funds and other institutional investors.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.